Jaguar Health Inc. [NASDAQ: JAGX] price plunged by -9.46 percent to reach at -$0.02. The company report on October 20, 2020 that Reminder: Jaguar Health Hosting Exclusive Virtual Educational Event, “Diarrhea Dialogues: Why Bowel Control is Critical to Supportive Care in Cancer”.
Leading Oncologists, Supportive Care Experts, and Patient Advocates Discuss Importance of Supportive Care for Cancer Patients and Address Debilitating Diarrhea Resulting from Cancer Therapy.
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
Virtual Event and Q&A 3:00 PM to 4:30 PM EDT on October 20.
A sum of 5288311 shares traded at recent session while its average daily volume was at 5.91M shares. Jaguar Health Inc. shares reached a high of $0.23 and dropped to a low of $0.2049 until finishing in the latest session at $0.21.
The average equity rating for JAGX stock is currently 2.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Jaguar Health Inc. [JAGX]:
Rodman & Renshaw have made an estimate for Jaguar Health Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 11, 2017.
The Average True Range (ATR) for Jaguar Health Inc. is set at 0.02, with the Price to Sales ratio for JAGX stock in the period of the last 12 months amounting to 1.86. The Price to Book ratio for the last quarter was 7.05, with the Price to Cash per share for the same quarter was set at 0.05.
JAGX Stock Performance Analysis:
Jaguar Health Inc. [JAGX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -27.01. With this latest performance, JAGX shares dropped by -28.75% in over the last four-week period, additionally sinking by -53.60% over the last 6 months – not to mention a drop of -68.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for JAGX stock in for the last two-week period is set at 21.17, with the RSI for the last a single of trading hit 12.85, and the three-weeks RSI is set at 27.41 for Jaguar Health Inc. [JAGX]. The present Moving Average for the last 50 days of trading for this stock 0.3416, while it was recorded at 0.2466 for the last single week of trading, and 0.5193 for the last 200 days.
Insight into Jaguar Health Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Jaguar Health Inc. [JAGX] shares currently have an operating margin of -420.75 and a Gross Margin at +33.93. Jaguar Health Inc.’s Net Margin is presently recorded at -667.32.
Return on Total Capital for JAGX is now -82.93, given the latest momentum, and Return on Invested Capital for the company is -217.73. Return on Equity for this stock declined to -220.53, with Return on Assets sitting at -99.52. When it comes to the capital structure of this company, Jaguar Health Inc. [JAGX] has a Total Debt to Total Equity ratio set at 36.78. Additionally, JAGX Total Debt to Total Capital is recorded at 26.89, with Total Debt to Total Assets ending up at 20.78. Long-Term Debt to Equity for the company is recorded at 5.02, with the Long-Term Debt to Total Capital now at 1.60.
Reflecting on the efficiency of the workforce at the company, Jaguar Health Inc. [JAGX] managed to generate an average of -$1,328,946 per employee. Receivables Turnover for the company is 4.28 with a Total Asset Turnover recorded at a value of 0.15.Jaguar Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.40 and a Current Ratio set at 0.50.
JAGX Stock EPS
With the latest financial reports released by the company, Jaguar Health Inc. posted -15.11/share EPS, while the average EPS was predicted by analysts to be reported at -5.29/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -185.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JAGX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Jaguar Health Inc. go to 40.00%.
Jaguar Health Inc. [JAGX] Insider Position Details
There are presently around $0 million, or 12.50% of JAGX stock, in the hands of institutional investors. The top three institutional holders of JAGX stocks are: WEDBUSH SECURITIES INC with ownership of 115,001, which is approximately New of the company’s market cap and around 10.37% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 109,183 shares of the stock with an approximate value of $23000.0 in JAGX stocks shares; and VIRTU FINANCIAL LLC, currently with $13000.0 in JAGX stock with ownership of nearly -43.783% of the company’s market capitalization.
Positions in Jaguar Health Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 10 institutional holders increased their position in Jaguar Health Inc. [NASDAQ:JAGX] by around 367,394 shares. Additionally, 2 investors decreased positions by around 48,568 shares, while 5 investors held positions by with 122,107 shares. The mentioned changes placed institutional holdings at 538,069 shares, according to the latest SEC report filing. JAGX stock had 6 new institutional investments in for a total of 348,628 shares, while 1 institutional investors sold positions of 2,206 shares during the same period.